Association between clinical profile and etiologic agent of pneumonia

M. Costa (Oporto, Portugal), A. Cipriano (Oporto, Portugal), F. Videira (Oporto, Portugal), S. Valdoleiros (Oporto, Portugal), A. Machado (Oporto, Portugal), J. Gomes (Oporto, Portugal), M. Abreu (Oporto, Portugal), H. Bastos (Oporto, Portugal)

Source: International Congress 2018 – Improving the outcomes of community-acquired pneumonia
Session: Improving the outcomes of community-acquired pneumonia
Session type: Poster Discussion
Number: 2027
Disease area: Respiratory infections

Congress or journal article abstractWebcastSlide presentationE-poster

Rating: 0
You must login to grade this presentation.

Share or cite this content

Citations should be made in the following way:
M. Costa (Oporto, Portugal), A. Cipriano (Oporto, Portugal), F. Videira (Oporto, Portugal), S. Valdoleiros (Oporto, Portugal), A. Machado (Oporto, Portugal), J. Gomes (Oporto, Portugal), M. Abreu (Oporto, Portugal), H. Bastos (Oporto, Portugal). Association between clinical profile and etiologic agent of pneumonia. 2027

You must login to share this Presentation/Article on Twitter, Facebook, LinkedIn or by email.

Member's Comments

No comment yet.
You must Login to comment this presentation.


Related content which might interest you:
The peculiarity of etiological agents of community-acquired pneumonia depends on the severity
Source: Eur Respir J 2006; 28: Suppl. 50, 2s
Year: 2006

Potential protective role of prior to diagnosis antibiotic treatment in community-acquired pneumonia: Clinical presentation and outcomes
Source: Annual Congress 2011 - Antimicrobial treatment and resistance in lower respiratory tract infections
Year: 2011


Clinical feature of Japanese patients with healthcare-associated pneumonia
Source: Annual Congress 2010 - Healthcare-associated pneumonia: ventilator-associated pneumonia and pneumonia in hospitalised patients
Year: 2010

Physician judgement is a crucial adjunct to pneumonia severity scores in low-risk patients
Source: Eur Respir J 2011; 38: 643-648
Year: 2011



Severe community acquired pneumonia: clinical and aetiological evaluation
Source: Eur Respir J 2007; 30: Suppl. 51, 673s
Year: 2007

Japanese guidelines for the management of community-acquired pneumonia: differential diagnosis of atypical pneumonia and bacterial pneumonia
Source: Eur Respir J 2006; 28: Suppl. 50, 374s
Year: 2006

Biomarkers for the prognostic assessment and disease severity evaluation in community-acquired pneumonia (CAP)
Source: Annual Congress 2010 - The prognosis of community-acquired pneumonia: old and new markers of severity
Year: 2010


The etiological agents of community-acquired pneumonia in our hospital
Source: Eur Respir J 2006; 28: Suppl. 50, 735s
Year: 2006

Characterization of the aetiological agent in patients with lung tuberculosis
Source: Eur Respir J 2006; 28: Suppl. 50, 11s
Year: 2006

The comparison of different methods of etiologic diagnosis of community-acquired pneumonia
Source: Annual Congress 2012 - Scores, biomarkers and risk factors in respiratory infections
Year: 2012

Relationship between etiologic diagnosis and prognosis in community-acquired pneumonia
Source: International Congress 2015 – Clinical issues in CAP: microbiological and radiological determinants
Year: 2015


Direct costs of treating community-acquired pneumonia do not necessarily correlate with clinical severity
Source: International Congress 2015 – Patient health gains related to the economic effectiveness of disease management programmes
Year: 2015


Characterization of the aetiological agent in patients with pulmonary tuberculosis
Source: Eur Respir J 2006; 28: Suppl. 50, 12s
Year: 2006

Clinical characteristics and prognostic features in infectious and non-infectious COPD exacerbations
Source: International Congress 2017 – Airway disease and exacerbations
Year: 2017

I like clinical pulmonary infection scores to define the role of clinical evaluation to diagnose pneumonia and ventilator-associated pneumonia
Source: Annual Congress 2009 - Diagnosis of ventilator-associated pneumonia: challenge the dogmas!
Year: 2009


Clinical manifestations and a prognostic factor of pneumocystis pneumonia without HIV infection
Source: Annual Congress 2011 - Infection in the immunocompromised host: infrequent aetiologies
Year: 2011

Evaluation of severity, inflammatory response and adherence to treatment guidelines impact on community-acquired pneumonia outcomes
Source: Annual Congress 2008 - Treatment and outcome in hospitalised patients with community-acquired pneumonia
Year: 2008


Assessment of urinary pneumococcal antigen for etiological diagnosis of community-acquired pneumonia
Source: Annual Congress 2003 - New aspects of community acquired pneumonia
Year: 2003


Biomarkers and clinical stability in community-acquired pneumonia
Source: Annual Congress 2009 - Assessment of severity in respiratory infections: severity scales and biomarkers
Year: 2009


Differential clinical and etiological features in young and elderly patients hospitalized due to community-acquired pneumonia
Source: Eur Respir J 2002; 20: Suppl. 38, 354s
Year: 2002